Tri-POC Tenofovir Dimer (>90%) is a high-purity pharmaceutical intermediate used in the production of nucleotide prodrugs. Its structure features a dimeric tenofovir backbone with multiple protective POC (propan-2-yloxycarbonyloxymethoxy) groups, making it a complex compound for advanced pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1093279-77-6
({[(Propan-2-yl)oxy]carbonyl}oxy)methyl hydrogen ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate
pharmaceutical intermediate
N-BOC-4-Hydroxypiperidine
pharmaceutical intermediate
4-Fluoro-3-formylbenzoic acid methyl ester
pharmaceutical intermediate
1-(6-bromopyridin-2-yl)-2,2,2-trifluoroethan-1-ol
pharmaceutical intermediate
N-(2-Pyrazinylcarbonyl)-L-phenylalanine sodium salt
pharmaceutical intermediate
Adefovir Dipivoxil Dimer
pharmaceutical intermediate
[(2R)-1-[6-[[[9-[(2R)-2-[bis(propan-2-yloxycarbonyloxymethoxy)phosphorylmethoxy]propyl]purin-6-yl]amino]methylamino]purin-9-yl]propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphinic acid
IGSVXJKHRBUXSS-JWQCQUIFSA-N
C[C@H](CN1C=NC2=C(N=CN=C21)NCNC3=C4C(=NC=N3)N(C=N4)C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)OCP(=O)(O)OCOC(=O)OC(C)C
—